Product Code: CHIT
TABLE OF CONTENTS
List Of Contents And Tables
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 2 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2016-2021
Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 8 Distribution of Consumer Health by Format: % Value 2016-2021
Table 9 Distribution of Consumer Health by Format and Category: % Value 2021
Table 10 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
Low levels of seasonal flu undermine sales of key products
Revival of busy lifestyles and familiar routines spurs recovery
Multinational players continue to lead the way
PROSPECTS AND OPPORTUNITIES
Return to more normal lifestyles set to support recovery
Strong emphasis on convenience
Growing confidence in self-medication
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2016-2021
Table 13 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 14 NBO Company Shares of Analgesics: % Value 2017-2021
Table 15 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 16 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
COVID-19 crisis leads to low level of flu, undermining demand
Mild allergy season
Resilience of medicated confectionery produces new leader
PROSPECTS AND OPPORTUNITIES
Recovery set to take some time after heavy impact from COVID-19
Strong demand for antihistamines/allergy remedies (systemic) expected
Multinationals set to confirm commitment to cough, cold and allergy (hay fever) remedies
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026
DIGESTIVE REMEDIES IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
Rebound expected as lifestyles return to normal
Downturn in demand for laxatives
Johnson & Johnson retains lead despite share erosion
PROSPECTS AND OPPORTUNITIES
Continued growth expected
Return of intestinal viruses to support demand for diarrhoeal remedies
Further development of natural trend
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2016-2021
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Table 26 NBO Company Shares of Digestive Remedies: % Value 2017-2021
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2018-2021
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2021-2026
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026
DERMATOLOGICALS IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
Slight improvement on previous year
Decline in topical germicidals/antiseptics and nappy (diaper) rash treatments
Bayer consolidates lead
PROSPECTS AND OPPORTUNITIES
Varying prospects across dermatologicals categories
Rise in sporting activity likely to bolster demand for topical antifungals
Return to more hectic lifestyles set to boost demand for vaginal antifungals
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2016-2021
Table 31 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 32 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 33 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
Table 35 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
NRT SMOKING CESSATION AIDS IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
NRT smoking cessation aids fails to take advantage of opportunities, and number of smokers rises again
Strong threat from e-vapour products and HTP
Johnson & Johnson remains dominant
PROSPECTS AND OPPORTUNITIES
Competition from smoking alternatives contributes to poor outlook for NRT smoking cessation aids
Rise in younger people smoking
Nicorette may go digital
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2016-2021
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026
SLEEP AIDS IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
Slight decline following the dynamic expansion of the previous year
Demand still high in 2021
Sleep aids remains fragmented
PROSPECTS AND OPPORTUNITIES
Lasting impact of pandemic and use of digital devices to support ongoing demand
Continued investment in innovation
Importance of advertising favours multinationals
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2016-2021
Table 45 Sales of Sleep Aids: % Value Growth 2016-2021
Table 46 NBO Company Shares of Sleep Aids: % Value 2017-2021
Table 47 LBN Brand Shares of Sleep Aids: % Value 2018-2021
Table 48 Forecast Sales of Sleep Aids: Value 2021-2026
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2021-2026
EYE CARE IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
Extended exposure to screens boosts demand for standard eye care
Dampened demand for allergy eye care
Domestic companies prominent in fragmented category
PROSPECTS AND OPPORTUNITIES
Increasing exposure to digital screens
Ageing population and increasing use of contact lenses to support growth
Growing demand for allergy eye care
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2016-2021
Table 51 Sales of Eye Care by Category: % Value Growth 2016-2021
Table 52 NBO Company Shares of Eye Care: % Value 2017-2021
Table 53 LBN Brand Shares of Eye Care: % Value 2018-2021
Table 54 Forecast Sales of Eye Care by Category: Value 2021-2026
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2021-2026
WOUND CARE IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
Revival of more active, away-from-home lifestyles boosts demand for wound care
Sticking plasters/adhesive bandages to rebound strongly
Innovation and strong marketing amongst leading players
PROSPECTS AND OPPORTUNITIES
Chemists/pharmacies to remain the main distribution channel
Continued focus on summer and spring, while increase in non-essential surgery will provide a boost
Consumer price-sensitivity to remain influential
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2016-2021
Table 57 Sales of Wound Care by Category: % Value Growth 2016-2021
Table 58 NBO Company Shares of Wound Care: % Value 2017-2021
Table 59 LBN Brand Shares of Wound Care: % Value 2018-2021
Table 60 Forecast Sales of Wound Care by Category: Value 2021-2026
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026
VITAMINS IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
Sales remain high as consumers focus on immunity and wellbeing
High demand for vitamins builds on longer-term trend
Bayer extends lead with focus on immunity
PROSPECTS AND OPPORTUNITIES
Continued growth on the back of long-term trend
E-commerce to continue to expand, though chemists/pharmacies remains dominant
Ongoing new product development
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2016-2021
Table 63 Sales of Vitamins by Category: % Value Growth 2016-2021
Table 64 Sales of Multivitamins by Positioning: % Value 2016-2021
Table 65 NBO Company Shares of Vitamins: % Value 2017-2021
Table 66 LBN Brand Shares of Vitamins: % Value 2018-2021
Table 67 Forecast Sales of Vitamins by Category: Value 2021-2026
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026
DIETARY SUPPLEMENTS IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
Rebound expected with revival of hectic modern lifestyles
Deeper trends re-emerging with return to more normal lifestyles
Sanofi retains lead, while Aboca continues to benefit from natural trend
PROSPECTS AND OPPORTUNITIES
Continued growth despite maturity
Return to doctors set to provide a boost to demand
Further M&A activity anticipated
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2016-2021
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2016-2021
Table 71 Sales of Dietary Supplements by Positioning: % Value 2016-2021
Table 72 NBO Company Shares of Dietary Supplements: % Value 2017-2021
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2018-2021
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2021-2026
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026
WEIGHT MANAGEMENT AND WELLBEING IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
Revival of interest in 2021
Positive performances from meal replacement and supplement nutrition drinks
Herbalife Italia responds well to challenges of new market conditions
PROSPECTS AND OPPORTUNITIES
Rise in obesity to generate demand
Poor outlook for weight loss supplements
Foodspring expected to maintain expansion
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2016-2021
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026
SPORTS NUTRITION IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
Consumers keen to return to physical activity as restrictions are eased
Some recovery in physical retailing
Hut.com retains lead, while Named sees strong growth
PROSPECTS AND OPPORTUNITIES
Ongoing recovery
Potential in areas such as plant-based products
Foodspring expected to continue to thrive
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2016-2021
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2016-2021
Table 84 NBO Company Shares of Sports Nutrition: % Value 2017-2021
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2018-2021
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2021-2026
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026
HERBAL/TRADITIONAL PRODUCTS IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
Modest growth as lifestyles return to normal
Demand for herbal/traditional cough, cold and allergy (hay fever) remedies dampened by low levels of cold and flu
Aboca benefits from vertically integrated operations
PROSPECTS AND OPPORTUNITIES
Positive outlook building on long-term trends
Strong growth in cough, cold and allergy (hay fever) remedies, and sleep aids
Revival of investment in new product development
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2016-2021
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2016-2021
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2021-2026
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2021-2026
PAEDIATRIC CONSUMER HEALTH IN ITALY
KEY DATA FINDINGS
2021 DEVELOPMENTS
Paediatric cough/cold remedies continues to suffer
Strong growth in paediatric vitamins and dietary supplements
Domestic players lead
PROSPECTS AND OPPORTUNITIES
Return of cold and seasonal flu set to support recovery
Falling birth rate presents ongoing challenge for nappy (diaper) rash treatments
Innovation in paediatric vitamins and dietary supplements
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2016-2021
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021
Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021
Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2017-2021
Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2018-2021
Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026
Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026
